Consistent with the survival curves, where patients with a low expression of KRT15 have a shorter survival span, KRT15, a specific biomarker of the BC_P06T subcluster, was significantly associated with advanced clinical pathological factors and unfavourable overall survival (OS). This evidence concerns the gene KRT15 and breast cancer.